Korro Bio, Inc. Quarterly Operating Income (Loss) in USD from Q3 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Korro Bio, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2018 to Q3 2024.
  • Korro Bio, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$23.3M, a 21.6% decline year-over-year.
  • Korro Bio, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$95.8M, a 84.7% decline year-over-year.
  • Korro Bio, Inc. annual Operating Income (Loss) for 2023 was -$84.5M, a 43.3% decline from 2022.
  • Korro Bio, Inc. annual Operating Income (Loss) for 2022 was -$59M, a 29.8% increase from 2021.
  • Korro Bio, Inc. annual Operating Income (Loss) for 2021 was -$84M, a 205% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$95.8M -$23.3M -$4.14M -21.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$91.6M -$24.1M -$5.72M -31.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$85.9M -$21.5M -$1.37M -6.81% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$84.5M -$26.9M -$32.7M -563% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 -$51.8M -$19.1M +$1.13M +5.56% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$53M -$18.4M +$2.87M +13.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$55.8M -$20.1M +$3.17M +13.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$59M $5.81M +$27.2M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 -$86.2M -$20.3M +$4.72M +18.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$90.9M -$21.3M -$3.79M -21.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$87.1M -$23.3M -$3.06M -15.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$84M -$21.4M -$11.1M -108% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-10
Q3 2021 -$72.9M -$25M -$19.6M -361% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$53.4M -$17.5M -$11.3M -182% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$42.1M -$20.2M -$14.5M -257% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 -$27.6M -$10.3M -$3.79M -58.4% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-15
Q3 2020 -$23.8M -$5.42M -$4.17M -333% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$19.6M -$6.2M +$819K +11.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$20.4M -$5.66M +$261K +4.41% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$20.7M -$6.49M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-29
Q3 2019 -$1.25M +$3.81M +75.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$7.02M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 -$5.92M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q3 2018 -$5.06M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.